William Ashton, Director at Sucampo Pharmaceuticals, Inc. (SCMP), sold 129,766 shares at $17.55 ($2.3M) on 2015-03-12, disclosed to the SEC on 2015-03-18.
Open-market sale of $2.3M SCMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.32 | 904 | $16K | 0.7% |
| 2 | $17.32 | 9,600 | $166K | 7.4% |
| 3 | $17.32 | 13,500 | $234K | 10.3% |
| 4 | $17.32 | 20,000 | $346K | 15.3% |
| 5 | $17.32 | 30,000 | $520K | 23.0% |
| 6 | $17.55 | 16,666 |
| $292K |
| 12.9% |
| 7 | $17.55 | 19,096 | $335K | 14.8% |
| 8 | $17.55 | 20,000 | $351K | 15.5% |
| Total | $17.42 avg | 129,766 | $2.3M | 100% |
| Filing → |
| SPPI | SELL | 2021-06-22 | $38K | — | Filing → |
| SPPI | SELL | 2020-06-23 | $16K | — | Filing → |
| SPPI | SELL | 2019-06-21 | $57K | — | Filing → |